Simplifying First Trimester Medical Abortion Follow-up

This study evaluates the usability of the multilevel pregnancy test among women undergoing medical abortion.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Medical Abortion

Sex eligibility

Female

Study type

Observational

Primary location

Gyumri Maternity Hospital, Gyumri, Armenia

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Have a first trimester pregnancy with a gestational age of ≤63 days;
Desire medical abortion with mifepristone and misoprostol and be medically eligible for that treatment, according to clinic protocol;
Be able to read and understand the local language or Russian;
Have access to a telephone;
Agree to follow all study procedures;
Have no contraindication to participation in the study, in the judgment of the site investigator or designee.

Treatment and study plan

Semiquantitative Multi-Level Pregnancy Test

Device

Primary outcomes

Understanding of the instructions for the multilevel pregnancy test

Time frame: 14 days
Ability to independently use the multilevel pregnancy tests

Time frame: 14 days
Ability to interpret the results of the multilevel pregnancy test

Time frame: 14 days

Sponsors and collaborators

Lead sponsor

Gynuity Health Projects

Other

Registry information

Important dates

Study start: 2017
Primary completion: 2017
Study completion: 2017
First posted: Jan 9, 2017
Registry last updated: Nov 6, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed